Award recordCONTRACT

OPTUM PHARMACY 801, INC.

PIID 36C26124N0577· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $497,706 net obligations· UEI K5MHR9JB9ND5· AZ

Description

HAZARDOUS COMPOUNDING DEOBLIGATE AND CLOSE

Base award description: CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO

First action · last action
2024-04-29 · 2025-05-27
Transactions
4
First transaction's obligation
$250,000
Base + all options value (sum of deltas)
$497,706
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C26124D0074
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 4 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$900,000$0Base award · 2024-04-29 · this action $250,000 · running total $250,000Modification P00001 · 2024-08-09 · this action $250,000 · running total $500,000Modification P00002 · 2024-09-12 · this action $400,000 · running total $900,000Modification P00003 · 2025-05-27 · this action -$402,294 · running total $497,706
  • Base2024-04-29+$250,000= $250,000
  • Mod P000012024-08-09+$250,000= $500,000
  • Mod P000022024-09-12+$400,000= $900,000
  • Mod P000032025-05-27-$402,294= $497,706
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-04-29+$250,000$250,000CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO
Mod P00001· FUNDING ONLY ACTION2024-08-09+$250,000$500,000CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO - INCREASE QTYS
Mod P00002· FUNDING ONLY ACTION2024-09-12+$400,000$900,000CONTINGENCY HAZARDOUS PHARMACEUTICAL COMPOUNDING - RENO - INCREASE QTYS
Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-05-27−$402,294$497,706HAZARDOUS COMPOUNDING DEOBLIGATE AND CLOSE

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI K5MHR9JB9ND5)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0168255-NETWORK CONTRACT OFFICE 15 (36C255) · Q517 · PHARMACY SERVICES$0FY2026
36C26126P0374261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$156,000FY2026
36C24226N0311242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$200,000FY2026
36C24226N0309242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$269,557FY2026
36C26026N0063260-NETWORK CONTRACT OFFICE 20 (36C260) · Q517 · PHARMACY SERVICES$557FY2026
36C24226N0127242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$20,584FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26124N0577_3600_36C26124D0074_3600 · retrieved 2026-09-26.